Recommendations of the Panel on Cost-effectiveness in Health and Medicine.
about
Surveillance for isocyanate asthma: a model based cost effectiveness analysisPharmacological and psychosocial interventions for night eating syndrome in adultsCost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysisThe cost-effectiveness of total joint arthroplasty: a systematic review of published literatureCost-effective diagnostic cardiovascular imaging: when does it provide good value for the money?Twenty years of cost-effectiveness analysis in medical imaging: are we improving?Cost of intensive care in a Norwegian University hospital 1997-1999Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal dataUsefulness of EQ-5D in assessing health status in primary care patients with major depressive disorderHealth-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPDComparing the clinical effectiveness of different new-born hearing screening strategies. A decision analysis.Neonatal hearing screening: modelling cost and effectiveness of hospital- and community-based screeningFundamentals of Clinical Outcomes Assessment for Spinal Disorders: Clinical Outcome Instruments and Applications.Economic evaluation in the field of mental health: conceptual basisCost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonanceAutism spectrum disorders: a review of measures for clinical, health services and cost-effectiveness applicationsCost-effectiveness of revascularization for limb preservation in patients with end-stage renal diseaseManaging incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategyYoga versus education for Veterans with chronic low back pain: study protocol for a randomized controlled trialCost Utility Analysis of the Cervical Artificial Disc vs Fusion for the Treatment of 2-Level Symptomatic Degenerative Disc Disease: 5-Year Follow-up.Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EUEpidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged > or =70Cost effectiveness of extended treatment with low molecular weight heparin (dalteparin) in unstable coronary artery disease: results from the FRISC II trialAnalysis of aspirin-associated risks in healthy individualsClinical and educational telepsychiatry applications: a reviewCost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspectiveCost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange programCost-effectiveness of treating multidrug-resistant tuberculosisDeterminants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and childrenPotential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infectionCost-effectiveness of apixaban compared with warfarin for stroke prevention in atrial fibrillationPopulation health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluationThe cost effectiveness of pandemic influenza interventions: a pandemic severity based analysisCost-effectiveness of treatment strategies for BRAF-mutated metastatic melanomaThe Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling StudyElectrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness AnalysisA cost-effectiveness analysis of "test" versus "treat" patients hospitalized with suspected influenza in Hong KongImpact of generic alendronate cost on the cost-effectiveness of osteoporosis screening and treatmentHealth and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling studyUsing Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.
P2860
Q23911463-EFA90AA5-A6EB-4B00-BE57-64DF2FA3AFCEQ24186735-DDFFABB5-CF6C-4DA9-A396-37D61131F2E4Q24554238-F4581FD9-3459-4DF5-ADAA-3EE554AD9E9FQ24622561-5106458E-6A8A-4AE4-AF17-847965D0FC29Q24628790-65866819-45EF-42B1-88CA-D185DB8CB437Q24650469-707850F4-2A00-42A4-B330-3412AADF57C2Q24794807-2CB53BC4-66D8-4EF4-886E-E04C2B3C0539Q24797831-9ADBF243-8DA1-441C-8CB9-5AED1F4BBD67Q24802062-198D7F12-603D-40B4-8D63-F0F20599F603Q24802387-EDFBC050-BDEB-4084-BC6A-9BDBBE8B2E9BQ24804934-E3342A72-4800-4144-B51F-045D1FA95727Q25255836-E32EC646-00D1-4B9F-A9F4-981514EF1F46Q26801597-B7287F6B-423D-41CE-84E8-4658DBD2E0DEQ26861743-B1CA37D8-BC73-4C49-B7F2-33E681A3794EQ26865761-A8C1D3B2-54AE-4315-A0BB-BBE44DEF8734Q27004613-1AA2F94F-B97D-4BB9-B41C-23FBEDFF7F60Q27308878-DAA2DC24-951D-4216-BCE2-B19C6A5A1F11Q27333241-37B4C53B-DC24-4537-BDB2-0B8D2E8E43F4Q27334106-518B3AB2-20B2-416E-965E-D56731786F96Q27346887-FBCF077B-7049-45FC-ADCD-D90B03523E4EQ28086893-9C76ABCC-93A1-4706-8264-4167587C3119Q28175859-BF450087-0F2D-47DE-B7A3-9FEBC9BD1800Q28194967-B3CBE35D-0FA8-4794-8723-C27687766018Q28211608-5CA406B1-A438-4E20-B362-3C4F0CBEB728Q28242481-562F7848-F50B-4DAA-8549-18BDE7F102D3Q28269638-DF14B8E6-7262-4370-9E23-A38F17806340Q28359547-4801732D-E9C7-4FF5-BB6A-C7399C7B27E4Q28469015-64653827-60CA-4F40-A56E-DB5CBCB5D3B9Q28477679-FCB20204-BDC5-4420-8FA7-88DBF2C01E3DQ28479103-2ADDC5E3-3448-4D9B-90F5-459B9AD9F836Q28484289-500FD282-993F-4CDE-BCB0-5C4C2DDC86E4Q28485280-8E58221B-38AA-45AB-BE13-E50C22CDEE66Q28486094-657274E1-AEF9-4880-94C0-0663238574E3Q28542877-201CA955-1379-44FE-A13B-0984168B7994Q28546995-872A5958-4055-45FA-9476-E032597F9666Q28548272-D93C9B02-2BC6-4934-B04B-680EB1CCB3E8Q28730856-A1C6D83D-2199-4CE1-B6CF-A4FFE05D287BQ28731336-E5D8D6E0-5F00-4E44-8B70-B631BCD52BEEQ30210097-0335AF13-AA12-421F-BF24-986A26081F3FQ30234498-8BF79E46-7040-47C2-BD10-2E11842DE0FE
P2860
Recommendations of the Panel on Cost-effectiveness in Health and Medicine.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Recommendations of the Panel on Cost-effectiveness in Health and Medicine.
@en
type
label
Recommendations of the Panel on Cost-effectiveness in Health and Medicine.
@en
prefLabel
Recommendations of the Panel on Cost-effectiveness in Health and Medicine.
@en
P2093
P1476
Recommendations of the Panel on Cost-effectiveness in Health and Medicine.
@en
P2093
J E Siegel
L B Russell
M C Weinstein
M S Kamlet
P304
P356
10.1001/JAMA.1996.03540150055031
P407
P577
1996-10-01T00:00:00Z